ESR1 and breast cancer: Previous results [15] and the current validation study show that high expression of miR-18a and miR-18b is associated with high proliferation, ERα negative, TNP and CK5/6 positivity, thereby indicating that these miRNAs could be markers for basal-like breast cancers.